AMENDMENT NO. 2 TO LICENSE AND SUPPLY AGREEMENT (RESTRUCTURING)License and Supply Agreement • May 13th, 2016 • Alexza Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This Amendment No. 2 to License and Supply Agreement (this “Second Amendment”) is executed on and effective as of February 23, 2016 (the “Second Amendment Effective Date”), by and between Alexza Pharmaceuticals, Inc., a company organized under the laws of the State of Delaware, United States (“Alexza”), and having a principal place of business at 2091 Stierlin Court, Mountain View, CA 94043, United States, and Teva Pharmaceuticals USA, Inc., a company organized under the laws of Delaware, United States (“Teva”), having a principal place of business at 1090 Horsham Road, North Wales, PA 19454, United States.
ALEXZA PHARMACEUTICALS, INC. STOCK ISSUANCE AGREEMENTStock Issuance Agreement • May 13th, 2016 • Alexza Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS STOCK ISSUANCE AGREEMENT (this “Agreement”) is made as of February 23, 2016, by and among Alexza Pharmaceuticals, Inc., a Delaware corporation (the “Company”), with its principal office at 2091 Stierlin Court, Mountain View, California 94043, and Teva Pharmaceuticals USA, Inc. (“Teva”).
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT BY AND BETWEEN ALEXZA PHARMACEUTICALS, INC. AND TEVA PHARMACEUTICALS USA, INC. Dated as of February 23, 2016Registration Rights Agreement • May 13th, 2016 • Alexza Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made as of February 23, 2016, by and between Alexza Pharmaceuticals, Inc., a Delaware corporation (“the “Company”), and Teva Pharmaceuticals USA, Inc., a Delaware corporation (“Teva”).
ContractPromissory Note and Agreement to Lend • May 13th, 2016 • Alexza Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED PROMISSORY NOTE AND AGREEMENT TO LEND HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW. NO SALE, TRANSFER, PLEDGE OR ASSIGNMENT OF THIS NOTE SHALL BE VALID OR EFFECTIVE UNLESS (A) SUCH TRANSFER IS MADE PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAW OR (B) THE HOLDER SHALL DELIVER TO THE COMPANY AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY ACCEPTABLE TO THE COMPANY THAT SUCH TRANSFER IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND OF ANY APPLICABLE STATE SECURITIES LAW.
